Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: A randomized, open-label study

International Clinical Psychopharmacology

Volumn 22, Issue 3, 2007, Pages 179-182

  Schindler, Frank ^a   Anghelescu, Ion G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Augmentation; Lamotrigine; Lithium; Treatment resistant depression

Indexed keywords

BENZODIAZEPINE; HYPNOTIC AGENT; LAMOTRIGINE; LITHIUM;

ADD ON THERAPY; ADULT; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SIDE EFFECT; TREATMENT RESPONSE; TREMOR; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; TRIAZINES;

EID: 34147159288     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328014823d     Document Type: Article

References (18)

1. Barbee JG, Jamhour NJ (2002). Lamotrigine as an augmentation agent in treatment-resistant depression. J Clin Psychiatry 63:737-741.
2. Barbosa L, Berk M, Virster M (2003). A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episode. J Clin Psychiatry 64:403-407.
3. Bauer M, Döpfner S (1999). Lithium augmentation in treatment-resistant depression: a meta-analysis of placebo-controlled studies. Int J Clin Psychopharmacol 19:427-434.
4. Bauer M, Hellweg R, Gräf KJ, Baumgartner A (1998). Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology 18:444-455.
5. Bauer M, Whybrow PC, Angst J, Versiani M, Möller HM, World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2002). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3:5-43.
6. Bowden CL, Calabrese JR, Ketter TA, Sachs GS, White RL, Thompson TR (2006). Impact of lamotrigine and lithium on weight in obese and non-obese patients with bipolar I disorder. Am J Psychiatry 163:199-201.
7. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (1999). A double-blind, placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 60:79-88.
8. Calabrese JR, Sullivan JR, Bowden CL, Suppes T, Goldberg JF, Sachs GS, et al. (2002). Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry 63:1012-1019.
9. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, et al., Lamictal 605 Study Group (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 64:1013-1024.
10. Fava M (2003). Diagnosis and treatment of treatment-resistant depression. Biol Psychiatry 53:649-659.
11. Gutierrez RL, McKercher R, Galea J, Jamison KL (2005). Lamotrigine augmentation strategy for patients with treatment-resistant depression. CNS Spectr 10:800-805.
12. Hirsch LJ, Weintraub DB, Buchsbaum R, Spencer HT, Straka T, Hager M, et al. (2006). Predictors of lamotrigine-associated rash. Epilepsia 47:318-322.
13. Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, et al. (2006). Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry 163:210-216.
14. Normann C, Hummel B, Scharer LO, Horn M, Grunze H, Walden J (2002). Lamotrigine as adjunct to acute depression: a placebo-controlled, double-blind study. J Clin Psychiatry 63:337-344.
15. Rocha FL, Hara C (2003). Lamotrigine augmentation in unipolar depression. Int Clin Psychopharmacol 18:97-99.
16. Sajatovic M, Gyulai L, Calabrese JR, Thompson TR, Wilson BG, White R, et al. (2005). Maintenance treatment outcome in older patients with bipolar I disorder. Am J Geriatr Psychiatry 13:305-311.
17. Thase ME (2002). What role do atypical antipsychotic drugs have in treatment-resistant depression? J Clin Psychiatry 63:95-103.
18. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. (2006). Outcomes with citalopram for depression using measurement-based care in STAR*D. Implication for clinical practice. Am J Psychiatry 163:28-40.